|
Volumn 13, Issue 6, 2002, Pages 501-505
|
Risedronate reduces the risk of first vertebral fracture in osteoporotic women
a b c d e f f g h i |
Author keywords
Bone mineral density; Osteoporosis; Risedronate; Vertebral fracture
|
Indexed keywords
CALCIUM;
PLACEBO;
RISEDRONIC ACID;
VITAMIN D;
ADULT;
AGED;
ARTICLE;
BONE DENSITY;
BONE MINERAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DUAL ENERGY X RAY ABSORPTIOMETRY;
FEMALE;
HUMAN;
OSTEOPOROSIS;
PRIORITY JOURNAL;
VERTEBRA FRACTURE;
AGED;
BONE DENSITY;
CALCIUM;
CALCIUM CHANNEL BLOCKERS;
ETIDRONIC ACID;
FEMALE;
FRACTURES, BONE;
HUMANS;
MIDDLE AGED;
OSTEOPOROSIS, POSTMENOPAUSAL;
RISK;
TIME FACTORS;
VITAMIN D;
|
EID: 0036303635
PISSN: 0937941X
EISSN: None
Source Type: Journal
DOI: 10.1007/s001980200061 Document Type: Article |
Times cited : (74)
|
References (17)
|